Optimi Health Corp. (NASDAQ:OPTH) Shares Shorted: Short Interest Up 109.1% in September

Optimi Health Corp. (NASDAQ:OPTH) saw a large increase in short interest in the month of September. As of September 15th, there was short interest totaling 20,500 shares, an increase of 109.1% from the August 31st total of 9,806 shares. Currently, 0.4% of the company’s stock are short sold. Based on an average daily volume of 91,023 shares, the days-to-cover ratio is presently 0.2 days.

Optimi Health Stock Performance

Shares of OPTH opened at $4.78 on Wednesday. Optimi Health has a fifty-two week low of $4.00 and a fifty-two week high of $6.40. The business has a 50-day simple moving average of $4.82. The stock has a market capitalization of $27.39 million and a PE ratio of -6.29. The company has a current ratio of 0.06, a quick ratio of 0.03 and a debt-to-equity ratio of 0.04.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on OPTH. Weiss Ratings raised Optimi Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, August 27th. Wall Street Zen raised Optimi Health to a “hold” rating in a research report on Saturday, July 25th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Optimi Health has a consensus rating of “Reduce”.

About Optimi Health

Optimi Health Corp. is a Canadian life sciences company focused on the development, production and distribution of psychedelic compounds and related products. The company’s activities are centered on psilocybin-based products and other emerging psychedelic formulations intended for potential therapeutic, research and experiential applications.

Optimi Health operates from Canada and has developed capabilities for the cultivation, extraction, formulation and processing of psychedelic and functional mushroom products.